The characteristics of anti-NXP-2-positive DM are severe muscle weakness, highly elevated serum creatinine kinase, dysphagia, subcutaneous edema, malignancy, and subcutaneous calcinosis. This evidence concerns the gene MORC3 and dermatomyositis.